Angelis Oncology, Inc. — Form D

Angelis Oncology, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-07-23. $400K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-07-23
• Form: D
• Accession: 0002146896-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Amount sold: $400K
• Investors: 1
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-591827

Issuer

• Name: Angelis Oncology, Inc.
• CIK: 0002146896
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 211 BELGRAVE AVE., SAN FRANCISCO, CA, 94117
• Phone: 415-215-5586

Officers, directors & promoters (1)

More

• CIK 2146896 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search